IQVIA Holdings | IQV - Cash And Equivalent



IQVIA Holdings reported $2.04B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Accenture USD 9.63B 1.14B May/2025
Adcock Ingram Holdings ZAR 79.14M 10.28M Dec/2024
Agilent USD 1.54B 49M Jul/2025
Bruker USD 92M 92.2M Jun/2025
Cardinal Health USD 3.87B 548M Jun/2025
Celltrion KRW 829.07B 829.07B Mar/2025
Charles River Laboratories USD 182.82M 46.53M Jun/2025
Cigna USD 4.33B 4B Jun/2025
Cognizant Technology Solutions USD 1.8B 184M Jun/2025
Cspc Pharmaceutical 6.78B 1.6B Dec/2024
CVS Health USD 11.79B 1.71B Jun/2025
Danaher USD 2.96B 964M Jun/2025
Dentsply International USD 359M 39M Jun/2025
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Divis Laboratories Ltd 4.15B 31.87B Mar/2025
Elevance Health USD 8.56B 1.06B Jun/2025
Hologic USD 1.74B 305.7M Jun/2025
Humana USD 4.04B 210M Jun/2025
IBM USD 11.94B 908M Jun/2025
Illumina USD 934M 179M Jun/2025
Infosys INR 3.2B 241.35B Jun/2025
Kangmei Pharma CNY 894.14M 120.63M Mar/2025
Knight Therapeutics CAD 5.81M 3.59M Sep/2024
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Laboratory Of America USD 647.3M 277.9M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
McKesson USD 2.42B 3.27B Jun/2025
Mettler Toledo International USD 61.82M 2.47M Jun/2025
Organigram Holdings 35.88M 8.42M Jun/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
Publicis EUR 3.64B 562M Dec/2024
Qiagen NV USD 733.82M 95.06M Jun/2025
Quest Diagnostics USD 319M 131M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Sartorius EUR 819M 20.5M Jun/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Tilray USD 189.7M 15.49M Nov/2024
UnitedHealth USD 32.02B 2.27B Jun/2025
Veeva Systems USD 1.93B 34.55M Jul/2025
Waters USD 367.22M 15.66M Jun/2025
Zz Pientze Pharmaceu 1.39B 93.82M Mar/2025